CAS 170939-95-4

RTI-177

Controlled Product

CAS: 170939-95-4

RTI-177 is a human analog of ceftiofur, which acts as a potent inhibitor of kinases. It has shown potential as an anticancer agent in Chinese hamster ovary cells by inducing apoptosis and inhibiting tumor growth. RTI-177 is also effective against cancer cell lines and has been shown to inhibit the activity of various kinases involved in cell proliferation and survival. This inhibitor has been found in urine samples from cancer patients, indicating its potential as a biomarker for early detection of cancer. RTI-177 is a promising candidate for the development of new protein kinase inhibitors with therapeutic potential for cancer treatment.

Formula: C₁₀H₈F₂N₄O

Purity: Min. 95%

Molecular weight: 240.21 g/mol

Ref: 3D-VGA93995